Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Vitae Pharmaceuticals presents new liver X receptor-beta agonists

Oct. 8, 2013

Novel myostatin inhibitors patented

Oct. 8, 2013

LC-510201, a new S1P1/S1P5 receptor agonist for multiple sclerosis

Oct. 8, 2013

MJFF grant supports Durin Technologies' blood test for Parkinson's disease

Oct. 7, 2013

Targeting LINGO1, a promising therapeutic strategy for multiple sclerosis

Oct. 7, 2013

KB-3944, a promising new drug for multiple sclerosis

Oct. 7, 2013

Isis Pharmaceuticals reaches milestone in phase II study in spinal muscular atrophy

Oct. 7, 2013

Addex Therapeutics reports preclinical data for ADX-71441 in Charcot-Marie-Tooth type 1A disease

Oct. 4, 2013

Scientists at Purdue Pharma disclose new Na(v)1.7 channel blockers

Oct. 4, 2013

Otsuka Pharmaceutical synthesizes novel monoamine reuptake inhibitors

Oct. 4, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 9, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 9, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome
BioWorld Science
The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...